Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2025-03-20 | 2025-05-08 | 253153 |
TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2017-03-14 | 2018-09-13 | 2218 |
TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2017-03-14 | 2018-09-13 | 2256 |
TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2017-08-01 | 2018-07-03 | 17899 |
TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2021-11-25 | 2021-12-02 | 149942 |
TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155180 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-12-08 | 2023-01-19 | 177529 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2020-02-21 | 2020-04-02 | 106916 |
TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110749 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-07-20 | 2023-07-28 | 199306 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-07-27 | 2023-08-18 | 200203 |
TEVA-NAPROXEN | 375MG | TABLET | Resolved | 2023-11-09 | 2024-01-11 | 209661 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-11-23 | 2024-01-11 | 211319 |
TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211970 |
TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2022-06-30 | 2022-08-19 | 163909 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-11-14 | 2023-01-19 | 174583 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-01 | 2024-04-25 | 218123 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-01 | 2024-05-09 | 218126 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-05-16 | 2024-06-13 | 228140 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-12-19 | 2025-02-28 | 246095 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
ACT VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65305 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65213 |
ACT ZOPICLONE | 5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65191 |
ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65218 |
AERMONY RESPICLICK | 55MCG | POWDER (METERED DOSE) | Discontinued | 2024-11-05 | 2024-11-05 | 242101 |
BORTEZOMIB FOR INJECTION | 3.5MG | POWDER FOR SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256094 |
CALMYLIN ACE | 10MG 7.5MG 100MG | SYRUP | Discontinued | 2024-06-28 | 2024-06-29 | 231574 |
CEFAZOLIN FOR INJECTION | 0.5G | POWDER FOR SOLUTION | Discontinued | 2019-08-08 | 2019-08-08 | 91175 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
CEFOXITIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2020-05-14 | 2020-05-14 | 115088 |
CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2021-02-12 | 2021-02-12 | 133886 |
CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |